About Hemarus
Hemarus is a Healthcare company based in Hyderabad (India) founded in 2003, and was acquired by Olam Agro in August 2011. Specialty plasma derived biopharmaceuticals for bleeding disorders. The company has 68 employees. The company was acqui-hired. Its focus areas include Life Sciences, Rare Diseases, Drugs and Hematology. Its legal entity in India is Hemarus Therapeutics Limited (U74220TG2003PLC041698).
Company details
Hemarus is an Indian Pharma manufacturer of plasma-derived biopharmaceuticals for bleeding disorders. Their products include human albumin, immunoglobulins, coagulation factor, fibrin sealant etc. Their plant has a capacity to process 130,000 litres of plasma annually.
- Headquarters Hyderabad, India
- Employees 68
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website hemarus.co.in
- Social LinkedIn
- Acquired by Olam Agro (Aug 2011)
- Legal Name Hemarus Therapeutics Limited
- Date of Incorporation 16 Sep, 2003
- Jurisdiction Hyderabad, Telangana, India
Associated legal entities of Hemarus
Hemarus operates through Hemarus Therapeutics Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Hemarus Therapeutics Limited CIN U74220TG2003PLC041698 | Active | 16 Sep 2003 | Hyderabad, Telangana | ₹0.0 Cr | 68 | 3 | View details |
Investors in Hemarus
Hemarus has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Olam Agro.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of farm gate sourcing-based processing and selling solutions for farmers | 1989 | olamgroup.com | Singapore, Singapore |
Investor details for Hemarus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Hemarus Therapeutics Limited (Hemarus)
Hemarus Therapeutics Limited is the primary company behind Hemarus. The board of Hemarus Therapeutics Limited currently have 3 directors; the longest-serving is Kavali Dharmendra, appointed in 2024. 17 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kavali Dharmendra DIN 07984298 | Director | 25 Oct 2024 | 2 yrs | Hemarus Therapeutics Limited |
| Balaraju Jittaboina DIN 10818541 | Director | 25 Oct 2024 | 2 yrs | Hemarus Therapeutics Limited |
| Santosh Kumar Surana DIN 10818902 | Director | 25 Oct 2024 | 2 yrs | Hemarus Therapeutics Limited |
Financials of Hemarus
Figures of Hemarus Therapeutics Limited, the primary company behind Hemarus, for FY 2025. Net loss was -₹3.1 Lakh (-34381% margin). EBITDA was -₹3.1 Lakh (-34377% margin). Revenue has grown at a compounded annual rate of -98% over three years and -93% over five years.
- -₹3.1 LakhNet loss · -34381% margin
- -₹3.1 LakhEBITDA · -34377% margin
- ₹10 LakhPaid-up capital
- 68Employees (provident fund records)
- -98%Revenue CAGR, 3 years
- -93%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Hemarus Therapeutics Limited are on its company page.
Detailed financial statements for Hemarus
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Hemarus
2 dated milestones of Hemarus across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Hemarus is founded.
- Exit Acquired by Olam Agro.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hemarus
Complete news archive for Hemarus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemarus
Hemarus was founded in 2003.
Hemarus is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Hemarus has 68 employees.
Annual revenue of Hemarus is $853.5K as on Mar 31, 2022.
Hemarus is an Indian Pharma manufacturer of plasma-derived biopharmaceuticals for bleeding disorders. Their products include human albumin, immunoglobulins, coagulation factor, fibrin sealant etc. Their plant has a capacity to process 130,000 litres of plasma annually.
Hemarus has 1 investor. Key investors include Olam Agro.
Hemarus operates through Hemarus Therapeutics Limited.
Yes. Hemarus was acquired by Olam Agro in August 2011.
The legal entities of Hemarus currently have 3 directors, including Kavali Dharmendra, Balaraju Jittaboina, Santosh Kumar Surana.

